Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

labatec pharma sa - propiverinum - gélules à libération modifiée - propiverini hydrochloridum 45 mg corresp. propiverinum 40.92 mg, acidum citricum, povidonum, lactosum monohydricum 8.5 mg, talcum, triethylis citras, magnesii stearas, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, ammonio methacrylatis copolymerum a, ammonio methacrylatis copolymerum b, matériel de la capsule: gelatina, e 171, e 172 (rubrum), e 172 (flavum), pro capsula. - incontinence, fréquence urinaire et urgence urinaire - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - lacosamidum - filmtabletten - lacosamidum 50.00 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum silicificatum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, e 171, talcum, e 132, e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - antiepileptikum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - lacosamidum - filmtabletten - lacosamidum 100.00 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum silicificatum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, e 171, talcum, e 172 (flavum), pro compresso obducto. - antiepileptikum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - lacosamidum - filmtabletten - lacosamidum 150.00 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum silicificatum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus) macrogolum 3350, e 171, talcum, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - antiepileptikum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - lacosamidum - filmtabletten - lacosamidum 200.00 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum silicificatum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171 macrogolum 3350, talcum, e 132, pro compresso obducto. - antiepileptikum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - asciminibum - filmtabletten - asciminibum 20 mg ut asciminibi hydrochloridum 21.62 mg, lactosum monohydricum 43.11 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carmellosum natricum conexum, poly(alcohol vinylicus), e 171, magnesii stearas, talcum, silica colloidalis anhydrica, lecithinum, e 172 (flavum), e 172 (rubrum), xanthani gummi, pro compresso obducto corresp. natrium max. 0.47 mg. - behandlung von erwachsenen patienten mit philadelphia-chromosom-positiver chronisch-myeloischer leukämie (ph+ cml) in der chronischen phase (cp) - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - asciminibum - filmtabletten - asciminibum 40 mg ut asciminibi hydrochloridum 43.24 mg, lactosum monohydricum 86.22 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carmellosum natricum conexum, poly(alcohol vinylicus), e 171, magnesii stearas, talcum, silica colloidalis anhydrica, lecithinum, e 172 (rubrum), e 172 (nigrum), xanthani gummi, pro compresso obducto corresp. natrium max. 0.93 mg. - behandlung von erwachsenen patienten mit philadelphia-chromosom-positiver chronisch-myeloischer leukämie (ph+ cml) in der chronischen phase (cp) - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - olmesartanum medoxomilum - filmtabletten - olmesartanum medoxomilum 10 mg, lactosum monohydricum 75.53 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, lactosum monohydricum 0.69 mg, macrogolum 3350, triacetinum, pro compresso obducto. - essentielle hypertonie - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - olmesartanum medoxomilum - filmtabletten - olmesartanum medoxomilum 20.0 mg, lactosum monohydricum 151.06 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, lactosum monohydricum 1.39 mg, macrogolum 3350, triacetinum, pro compresso obducto. - essentielle hypertonie - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - olmesartanum medoxomilum - filmtabletten - olmesartanum medoxomilum 40.0 mg, lactosum monohydricum 302.12 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, lactosum monohydricum 2.77 mg, macrogolum 3350, triacetinum, pro compresso obducto. - essentielle hypertonie - synthetika